Inventiva
50 rue de Dijon
Daix
21121
France
Tel: 33-3-80-44-75-00
Website: http://www.inventivapharma.com/
Email: info@inventivapharma.com
About Inventiva
Inventiva is a biopharmaceutical company with several drug candidates at clinical and preclinical stage whose objective is to develop and provide patients with new therapies. The focus of the company’s research and developmentdepartment targets three promising areas, namely fibrotic diseases, the treatment of certain forms of lysosomal diseases and oncology with a priority for the development of indications for orphan diseases for which the unmet medical need and the regulations in force allow an accelerated development.YEAR FOUNDED:
2011
LEADERSHIP:
Founder and CEO: Frédéric Cren
Founder and CSO: Pierre Broqua
CFO: Jean Volatier
CMO: Jean-Louis Abitbol
JOBS:
Please click here for Inventiva job opportunities.
CLINICAL TRIAL:
Please click here for clinical trial information.
FOLLOW INVENTIVA:
Tweets by Inventiva Pharma
41 articles with Inventiva
-
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business.
-
BioSpace Global Roundup, Nov. 12
11/12/2020
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines. -
While the world has largely been focused on the development of vaccines and therapeutics for COVID-19, the U.S. FDA has remained busy lining up potential approvals of medications for other diseases and illnesses.
-
BioSpace Global Roundup, Oct. 15
10/15/2020
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines. -
NASH is a metabolic disease similar to cirrhosis of the liver, but occurs in people who drink little, if any, alcoholic.
-
BioSpace Global Roundup, May 28
5/28/2020
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses. -
BioSpace Global Roundup, May 21
5/21/2020
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations. -
BioSpace Global Roundup, April 9
4/9/2020
Biopharma companies from across the globe provide updates to their business operations and pipelines. -
BioSpace Global Roundup, Dec. 5
12/5/2019
Companies from across the globe provide updates on their business and pipelines. -
BioSpace Global Roundup, Oct. 3
10/3/2019
Companies from across the globe share information on their business and pipelines. -
BioSpace Global Roundup, Sept. 26
9/26/2019
Companies from across the globe share updates on their business and pipelines. -
BioSpace Global Roundup, Sept. 12
9/12/2019
Companies and organizations from across Europe, Asia and North America share updates on their business and pipelines. -
BioSpace Global Roundup, Sept. 5
9/5/2019
Companies from across Europe and Asia share updates on their business and pipelines. -
BioSpace Global Roundup, Aug. 29
8/29/2019
Companies from across the globe provide updates on their business and pipelines. -
BioSpace Global Roundup, Aug. 22
8/22/2019
Companies from across the globe provide updates on their business and pipelines. -
BioSpace Global Roundup, June 13
6/13/2019
Companies from across the globe share business and pipeline updates. -
Companies across Europe and Asia provide information about deal, clinical trials and more, with news from Synaptive Medical, Epic, Inventiva, Velabs, and more.
-
Shares of France-based Inventiva have plunged more than 45 percent after the company reported that its experimental treatment for a rare autoimmune disease failed to hit primary and secondary endpoints in a mid-stage trial.
-
Inventiva to Present at Two Upcoming Investor Conferences
11/13/2017
Inventiva today announced that Frédéric Cren, CEO of Inventiva, will present at two upcoming investor conferences.
-
Inventiva: Third-Quarter 2017 Financial Information
11/7/2017
Revenues of €6.0 million, an increase of 4.6% compared to 2016